(Q27681860)

4

0 references

Anna Di Fiore

1

0 references

Claudiu T Supuran

3

0 references

author name string

Alfonso Maresca

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

2

0 references

language of work or name

English

0 references

publication date

11 September 2012

0 references

published in

Chemical Communications

0 references

volume

48

0 references

issue

70

0 references

page(s)

8838-40

0 references

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Carbonic anhydrase inhibitors and activators for novel therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Carbonic anhydrase IX as a target for designing novel anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Therapeutic potential of sulfamides as enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Recent advances in MMP inhibitor design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Targeting histone deacetylase inhibitors for anti-malarial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Refined structure of human carbonic anhydrase II at 2.0 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Carbonic anhydrase inhibitors: Inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H

Carbonic Anhydrase and Matrix Metalloproteinase Inhibitors: Sulfonylated Amino Acid Hydroxamates with MMP Inhibitory Properties Act as Efficient Inhibitors of CA Isozymes I, II, and IV, andN-Hydroxysulfonamides Inhibit Both These Zinc Enzymes1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CC34275H